ENTITY

ProKidney (PROK US)

3
Analysis
Health Care • United States
ProKidney Corp operates as a biotech company. The Company develops therapies that repairs and restores diseased kidneys using a patient's own cells and may prevent or delay dialysis or transplant. ProKidney serves customers worldwide.
more
bullish•ProKidney
•19 Jan 2022 11:12•Syndicated

The Nightcap from SPAC Track

Social Capital Suvretta Holdings Corp. III (DNAC: no warrants, common +0.01%) & ProKidney. Vishal Garg, founder and CEO of digital mortgage lender...

Logo
342 Views
Share
bullish•Gores Holdings IX
•14 Jan 2022 12:03•Syndicated

These Dealmakers will Make or Break SPACs in 2022

While a majority of SPAC dealmakers have faced issues such as raising adequate financing for deals or acquiring high-quality merger targets, Serial...

Logo
subSPAC
617 Views
Share
bullish•ProKidney
•10 Jan 2022 11:38•Syndicated

The Nightcap from SPAC Track

Exactly one year to the day after Chamath Palihapitiya’s last SPAC deal announcement, we have news that one of his four biotech SPACs is in talks...

Logo
323 Views
Share
No more insights
x